4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000950170-23-024600
PRESIDENT & CEO sold 31,655 shares at an average $41.41 ($1,310,931)
- PRESIDENT & CEO acquired 69,340 shares (option exercise)
- PRESIDENT & CEO gave up 12,383 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Option exercise | +42,592 | $9.44 | $402,068 | 48,592 | D |
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Shares withheld for taxes | −7,310 | $41.84 | $305,850 | 41,282 | D |
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Sale | −17,069 | $41.44 | $707,339 | 24,213 | D |
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Option exercise | +20,576 | $9.85 | $202,674 | 44,789 | D |
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Shares withheld for taxes | −3,902 | $41.84 | $163,260 | 40,887 | D |
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Sale | −13,179 | $41.37 | $545,215 | 27,708 | D |
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Option exercise | +6,172 | $9.85 | $60,794 | 33,880 | D |
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Shares withheld for taxes | −1,171 | $41.84 | $48,995 | 32,709 | D |
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Sale | −1,407 | $41.49 | $58,376 | 31,302 | D |
| Derivatives | |||||||
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Option exercise · Stock Option (Right to Buy) | −42,592 | 0 | D | ||
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Option exercise · Stock Option (Right to Buy) | −20,576 | 0 | D | ||
| MORTIMER IAN PRESIDENT & CEO | 2023-05-24 | Option exercise · Stock Option (Right to Buy) | −6,172 | 0 | D | ||
| Open-market sales · 31,655 sh · avg $41.41 · $1,310,931 | |||||||
Loading xslF345X04/ownership.xml…